models and mixture-of-experts architectures to process biological, chemical, and materials datasets for drug discovery and materials research. BioX AI also offers the PeptAI Autonomous Agent Fleet, a set of computational agents that run continuous pipelines to advance peptide drug discovery. Additional platform capabilities support precision medicine, cell and gene therapy, regenerative medicine, immunotherapy, and drug delivery design. In clean energy and materials science, its tools assist with accelerated materials discovery, predictive performance modeling, and optimization of battery and solar cell systems.